Surgical pathology of adenocarcinomas arising around or within the gastroesophageal junction
- PMID: 36001283
- PMCID: PMC9852148
- DOI: 10.1007/s13304-022-01360-z
Surgical pathology of adenocarcinomas arising around or within the gastroesophageal junction
Abstract
Classification of adenocarcinomas (AC) arising around or within the gastroesophageal junction (GEJ) is hampered by major morphologic and phenotypic overlaps. We reviewed the surgical pathology of esophagectomy specimens of 115 primary resected AC of the esophagus as defined by the 5th edition of the WHO classification regarding the anatomical site of the tumor, with corresponding categorization according to the Siewert AEG Classification and the preceding 4th edition of the WHO (discriminating esophageal adenocarcinomas/EAC and adenocarcinomas of the gastroesophageal junction/AdGEJ), and further histology findings. In addition, immunohistochemistry (IHC) for CDX2, CK7, CK20, MUC2, MUC5AC and MUC6 was performed. Sixty-eight cases were Siewert AEG type I and 47 cases Siewert AEG type II. Out of the AEG I tumors, 26 were classified as AdGEJ. Regardless of the classification system, more proximally located tumors showed less aggressive behavior with lower rates of lymph node metastases, lymphatic, venous and perineural invasion, better histological differentiation (p < 0.05 each) and were more frequently associated with pre-neoplastic Barrett's mucosa (p < 0.001). Histologically, the tumors displayed intestinal morphology in the majority of cases. IHC showed non-conclusive patterns with a frequent CK7+/CK20+ immunophenotype in all tumors, but also a gastric MUC5AC+ and MUC6+ phenotype in some proximal tumors. In conclusion, histology of the tumors and IHC failed to distinguish reliably between more proximal and more distal tumors. The presence of Barrett's mucosa rather than location alone, however, may help to further differentiating adenocarcinomas arising in this region and may be indicative for a particular biologic type.
Keywords: Adenocarcinoma; Biomarker; Esophagus; Gastroesophageal junction; Intestinal metaplasia; Surgical pathology.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
Similar articles
-
Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.Histopathology. 2003 Aug;43(2):127-34. doi: 10.1046/j.1365-2559.2003.01680.x. Histopathology. 2003. PMID: 12877727
-
The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma.Mod Pathol. 2011 Sep;24(9):1177-90. doi: 10.1038/modpathol.2011.77. Epub 2011 May 13. Mod Pathol. 2011. PMID: 21572404
-
Is Barrett's metaplasia the source of adenocarcinomas of the cardia?Arch Surg. 1994 Jun;129(6):609-14. doi: 10.1001/archsurg.1994.01420300051007. Arch Surg. 1994. PMID: 8204035
-
[Carcinoma of the oesophagogastric junction and Barrett's esophagus: an almost clear oncologic model?].Chirurg. 2003 Aug;74(8):703-8. doi: 10.1007/s00104-003-0704-9. Chirurg. 2003. PMID: 12928790 Review. German.
-
Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers.Gastric Cancer. 2020 Jan;23(1):3-9. doi: 10.1007/s10120-019-01022-x. Epub 2019 Nov 6. Gastric Cancer. 2020. PMID: 31691875 Review.
Cited by
-
Diagnostic challenges of rarely well-differentiated adenocarcinoma of the stomach.Pathol Oncol Res. 2025 Jul 7;31:1612163. doi: 10.3389/pore.2025.1612163. eCollection 2025. Pathol Oncol Res. 2025. PMID: 40692725 Free PMC article.
-
Predictive value of baseline CT imaging features combined with serum biomarkers for neoadjuvant chemotherapy response in adenocarcinoma of the gastroesophageal junction.Am J Cancer Res. 2025 Apr 25;15(4):1955-1971. doi: 10.62347/XLSV6197. eCollection 2025. Am J Cancer Res. 2025. PMID: 40371150 Free PMC article.
References
-
- WHO Classification of Tumours Editorial Board . WHO classification of tumours series. Geneva: WHO; 2019. Digestive System Tumours.
-
- Bosman ND, Carneiro FT, Hruban F, Theise RH, editors. WHO classification of tumours of the digestive system. 4. Geneva: IARC/WHO; 2010.
-
- Brierley JD, Gospodarowicz MK, Wittekind C. “TNM classification of malignant tumours—8th edition”, Union Int. Cancer Control. 2017 doi: 10.1002/9780471420194.tnmc26.pub3. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous